van der Elst Martine C J, Wunderink Yvette S, Ellenbroek Bart A, Cools Alexander R
Molecular Neurobiology Section, Department of Cognitive Neurosciences, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
Psychopharmacology (Berl). 2007 Jan;190(1):93-102. doi: 10.1007/s00213-006-0587-9. Epub 2006 Oct 10.
Amphetamine is often used to mimic certain aspects of schizophrenia in laboratory animals, such as a decreased prepulse inhibition.
Apomorphine-susceptible and apomorphine-unsusceptible rats represent a well-characterized animal model for individual differences in the sensitivity to dopaminergic drugs. Moreover, apomorphine-susceptible rats show a wide variety of schizophrenia-like abnormalities. The differential response to administration of amphetamine (1-4 mg/kg, i.p.) was investigated in these two rat lines using the prepulse inhibition paradigm. Because amphetamine promotes dopamine release, the cellular mechanism underlying the line-specific effects of amphetamine was investigated by administration of alpha-methyl-para-tyrosine (aMpT) and reserpine, substances that are known to deplete the cytosolic dopamine pool and the vesicular dopamine pool, respectively, the former being primarily implicated in mediating the effects of amphetamine.
All doses of amphetamine decreased prepulse inhibition in apomorphine-susceptible rats, whereas only the highest doses (2 and 4 mg/kg, i.p.) of amphetamine decreased prepulse inhibition in apomorphine-unsusceptible rats. Alpha-methyl-para-tyrosine, but not reserpine, blocked the amphetamine-induced disruption in prepulse inhibition in apomorphine-unsusceptible rats, whereas both substances alone had no effect in apomorphine-susceptible rats. However, the combination of alpha-methyl-para-tyrosine and reserpine did block the amphetamine-induced effects in the latter rat line.
The present study suggests that apomorphine-susceptible rats are more sensitive to systemic administration of amphetamine than apomorphine-unsusceptible rats. In addition, the data show that the cellular mechanism underlying the effects of amphetamine differs between apomorphine-susceptible and apomorphine-unsusceptible rats. Whereas the effects of amphetamine on prepulse inhibition in apomorphine-unsusceptible rats just require the alpha-methyl-para-tyrosine sensitive dopamine pool, the effects in apomorphine-susceptible rats require both the alpha-methyl-para-tyrosine sensitive and the reserpine sensitive dopamine pool. Because apomorphine-susceptible rats share many features with schizophrenic patients, these data open the perspective that in these patients amphetamine may induce dopamine release from both types of dopamine pool. This might provide an explanation for the increased dopamine release after this psychostimulant drug in patients vs controls.
苯丙胺常用于在实验动物中模拟精神分裂症的某些方面,如前脉冲抑制降低。
阿扑吗啡敏感和阿扑吗啡不敏感大鼠是一种特征明确的动物模型,用于研究对多巴胺能药物敏感性的个体差异。此外,阿扑吗啡敏感大鼠表现出多种类似精神分裂症的异常。使用前脉冲抑制范式在这两种大鼠品系中研究了给予苯丙胺(1 - 4毫克/千克,腹腔注射)后的差异反应。由于苯丙胺促进多巴胺释放,通过给予α - 甲基 - 对 - 酪氨酸(aMpT)和利血平来研究苯丙胺品系特异性作用的细胞机制,已知这两种物质分别消耗胞质多巴胺池和囊泡多巴胺池,前者主要参与介导苯丙胺的作用。
所有剂量的苯丙胺均降低了阿扑吗啡敏感大鼠的前脉冲抑制,而只有最高剂量(2和4毫克/千克,腹腔注射)的苯丙胺降低了阿扑吗啡不敏感大鼠的前脉冲抑制。α - 甲基 - 对 - 酪氨酸而非利血平阻断了阿扑吗啡不敏感大鼠中苯丙胺诱导的前脉冲抑制破坏,而单独使用这两种物质对阿扑吗啡敏感大鼠均无影响。然而,α - 甲基 - 对 - 酪氨酸和利血平的组合确实阻断了后者大鼠品系中苯丙胺诱导的效应。
本研究表明,阿扑吗啡敏感大鼠比阿扑吗啡不敏感大鼠对苯丙胺的全身给药更敏感。此外,数据表明,苯丙胺作用的细胞机制在阿扑吗啡敏感和阿扑吗啡不敏感大鼠之间存在差异。虽然苯丙胺对阿扑吗啡不敏感大鼠前脉冲抑制的作用仅需要α - 甲基 - 对 - 酪氨酸敏感的多巴胺池,但对阿扑吗啡敏感大鼠的作用需要α - 甲基 - 对 - 酪氨酸敏感和利血平敏感的多巴胺池。由于阿扑吗啡敏感大鼠与精神分裂症患者有许多共同特征,这些数据为在这些患者中苯丙胺可能从两种类型的多巴胺池中诱导多巴胺释放提供了观点。这可能为该精神兴奋药物在患者与对照组中导致多巴胺释放增加提供一种解释。